Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiency Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002131
What this trial is testing

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Otsuka America Pharmaceutical 28
Large-scale testing (Phase 3)Study completedNCT00002445
What this trial is testing

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Who this might be right for
Sarcoma, KaposiHIV Infections
Cytran 200
Large-scale testing (Phase 3)Study completedNCT03311945
What this trial is testing

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Who this might be right for
HIV InfectionsHIV-1-infectionHIV Seropositivity
Judit Pich 33
Early research (Phase 1)Study completedNCT01016730
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Not applicableUnknownNCT06125457
What this trial is testing

Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission

Who this might be right for
COVID-19
University Hospital, Strasbourg, France 120
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00000781
What this trial is testing

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,292
Early research (Phase 1)UnknownNCT01881581
What this trial is testing

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 56
Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Early research (Phase 1)Study completedNCT01138072
What this trial is testing

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 14
Post-approval studies (Phase 4)Study completedNCT00543101
What this trial is testing

Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

Who this might be right for
HIV Infections
Community Research Initiative of New England 24
Early research (Phase 1)Study completedNCT00582101
What this trial is testing

Family-Based HIV Prevention for Latinos

Who this might be right for
HIV Infections
Rhode Island Hospital 80
Not applicableAvailableNCT03145545
What this trial is testing

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

Who this might be right for
LeukemiaBone Marrow Failure SyndromeImmunodeficiencies
Children's Hospital of Philadelphia
Large-scale testing (Phase 3)Study completedNCT02103439
What this trial is testing

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Who this might be right for
HepatitisHepatitis CHepatitis C/ Human Immunodeficiency Virus Coinfection
Biocad 140
Not applicableEnrolling By InvitationNCT07541131
What this trial is testing

Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT)

Who this might be right for
Stigma, SocialDrug Abuse IllicitHIV (Human Immunodeficiency Virus)
University of California, San Diego 80
Large-scale testing (Phase 3)Study completedNCT00002339
What this trial is testing

Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Who this might be right for
Candidiasis, EsophagealHIV Infections
Pfizer 100
Not applicableStudy completedNCT00002113
What this trial is testing

A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer 64
Not applicableStudy completedNCT07009262
What this trial is testing

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 88
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Next Page